Lista de obras - Hans Prenen - Dominio Público Uruguay

A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: the IGNITE-1 study

artículo científico publicado en 2017

A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients.

artículo científico publicado en 2015

Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRAD842V mutation.

artículo científico publicado en 2008

Administration of imatinib mesylate in rats impairs the neonatal development of intramuscular interstitial cells in bladder and results in altered contractile properties

artículo científico publicado en 2013

Analysis of the formalin-fixed paraffin-embedded tissue proteome: pitfalls, challenges, and future prospectives.

artículo científico publicado en 2013

Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer ⬇️

artículo científico publicado el 25 de enero de 2013

Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: The role of anti‐VEGF and anti‐EGFR antibodies ⬇️

artículo científico publicado el 15 de diciembre de 2010

Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding

scientific article published in 2023

Cancer risk in immune-mediated inflammatory diseases (IMID).

artículo científico publicado en 2013

Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus

artículo científico publicado en 2012

Comparison of multiple protein extraction buffers for GeLC-MS/MS proteomic analysis of liver and colon formalin-fixed, paraffin-embedded tissues.

artículo científico publicado en 2015

Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy

scientific article published in Nature Communications

Current and future biomarkers in the treatment of colorectal cancer.

artículo científico publicado en 2016

Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study.

artículo científico

Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate

artículo científico publicado en 2006

Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review.

artículo científico publicado en 2006

Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization

artículo científico publicado en 2014

Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization

Establishment of a mouse gastrointestinal stromal tumour model and evaluation of response to imatinib by small animal positron emission tomography

artículo científico publicado en 2006

Expression of FOXP1 and Colorectal Cancer Prognosis

artículo científico publicado en 2015

Gastric cancer

artículo científico publicado en 2016

Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis ⬇️

artículo científico publicado en 2016

Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma

artículo científico publicado en 2016

Hypomagnesaemia and targeted anti-epidermal growth factor receptor (EGFR) agents ⬇️

artículo científico publicado el 24 de noviembre de 2011

Imatinib for the treatment of patients with unresectable or metastatic malignant KIT-positive gastrointestinal stromal tumours: an open-label Belgian trial

scientific article published on 01 October 2006

Intrahepatic therapy for liver-dominant metastatic colorectal cancer

artículo científico publicado en 2015

Iron deficiency in gastrointestinal oncology

artículo científico publicado en 2015

Is There Merit for MET-Targeted Therapies in Gastroesophageal Cancer?

artículo científico publicado en 2017

Lessons From the Adjuvant Bevacizumab Trial on Colon Cancer: What Next?

artículo científico publicado en 2010

MET is required for the recruitment of anti-tumoural neutrophils

artículo científico publicado en 2015

Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis

artículo científico publicado en 2016

Management of adverse events during treatment of gastrointestinal cancers with epidermal growth factor inhibitors.

artículo científico publicado en 2017

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

artículo científico publicado en 2005

Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis

artículo científico publicado en 2015

Minimally invasive liver surgery for metastases from colorectal cancer: oncologic outcome and prognostic factors.

artículo científico publicado en 2012

Molecular genetics of colorectal cancer

artículo científico publicado en 2014

Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients

artículo científico publicado en 2006

Oncological Management of Unresectable Liver Metastases ⬇️

artículo científico publicado el 23 de noviembre de 2012

PD-030Prospective non-interventional study to collect data on the use of bevacizumab and conventional chemotherapy for the treatment of previously untreated metastatic colorectal cancer in patient's ≥70 years.

artículo científico publicado en 2016

PHD1 regulates p53-mediated colorectal cancer chemoresistance.

artículo científico publicado en 2015

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

artículo científico publicado en 2015

Phase II open-label study to assess efficacy and safety of lenalidomide in combination with cetuximab in KRAS-mutant metastatic colorectal cancer

artículo científico publicado en 2013

Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma

artículo científico publicado en 2015

Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus ⬇️

artículo científico publicado en 2014

Postgastrectomy protein-losing cytomegalovirus jejunitis in an immunocompromised patient.

artículo científico publicado en 2014

Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.

artículo científico publicado en 2016

Progression of Barrett's esophagus toward esophageal adenocarcinoma: an overview

artículo científico publicado en 2016

Proteomic analysis of formalin-fixed paraffin-embedded colorectal cancer tissue using tandem mass tag protein labeling.

artículo científico publicado en 2013

Pulmonary lymphangitic carcinomatosis as a primary manifestation of gastric carcinoma in a young adult: a case report and review of the literature

artículo científico publicado en 2012

RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review. ⬇️

artículo científico publicado en 2019

RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment

artículo científico publicado en 2018

Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study).

artículo científico publicado en 2016

Refractory Metastatic Colorectal Cancer: Current Challenges and Future Prospects

scientific article published on 15 July 2020

Relevance of Geriatric Assessment in Older Patients With Colorectal Cancer.

artículo científico publicado en 2016

Role of targeted agents in metastatic colorectal cancer.

artículo científico

Safety and efficacy of doxorubicin-eluting superabsorbent polymer microspheres for the treatment of liver metastases from neuroendocrine tumours: preliminary results

artículo científico publicado en 2017

Salivary gland carcinomas: molecular abnormalities as potential therapeutic targets.

scientific article published on May 2008

Simultaneous determination of AMN107 and Imatinib (Gleevec, Glivec, STI571) in cultured tumour cells using an isocratic high-performance liquid chromatography procedure with UV detection

artículo científico publicado en 2006

Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions

scientific article published on 01 February 2020

Successful application of endoscopic ultrasound-guided fine needle biopsy to establish pancreatic patient-derived tumor xenografts: a pilot study

artículo científico publicado en 2016

Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status

artículo científico publicado en 2017

Tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome.

artículo científico publicado en 2016

The impact of frailty on postoperative outcomes in individuals aged 65 and over undergoing elective surgery for colorectal cancer: A systematic review

artículo científico publicado en 2016

The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia.

artículo científico publicado en 2017

Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancer

artículo científico publicado en 2015

Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancer

artículo científico publicado en 2016

Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival.

artículo científico publicado en 2015

Lista de obras de Hans Prenen

A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: the IGNITE-1 study

A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients.

Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRAD842V mutation.

Administration of imatinib mesylate in rats impairs the neonatal development of intramuscular interstitial cells in bladder and results in altered contractile properties

Analysis of the formalin-fixed paraffin-embedded tissue proteome: pitfalls, challenges, and future prospectives.

Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer ⬇️

Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: The role of anti‐VEGF and anti‐EGFR antibodies ⬇️

Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding

Cancer risk in immune-mediated inflammatory diseases (IMID).

Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus

Comparison of multiple protein extraction buffers for GeLC-MS/MS proteomic analysis of liver and colon formalin-fixed, paraffin-embedded tissues.

Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy

Current and future biomarkers in the treatment of colorectal cancer.

Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study.

Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate

Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review.

Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization

Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization

Establishment of a mouse gastrointestinal stromal tumour model and evaluation of response to imatinib by small animal positron emission tomography

Expression of FOXP1 and Colorectal Cancer Prognosis

Gastric cancer

Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis ⬇️

Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma

Hypomagnesaemia and targeted anti-epidermal growth factor receptor (EGFR) agents ⬇️

Imatinib for the treatment of patients with unresectable or metastatic malignant KIT-positive gastrointestinal stromal tumours: an open-label Belgian trial

Intrahepatic therapy for liver-dominant metastatic colorectal cancer

Iron deficiency in gastrointestinal oncology

Is There Merit for MET-Targeted Therapies in Gastroesophageal Cancer?

Lessons From the Adjuvant Bevacizumab Trial on Colon Cancer: What Next?

MET is required for the recruitment of anti-tumoural neutrophils

Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis

Management of adverse events during treatment of gastrointestinal cancers with epidermal growth factor inhibitors.

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis

Minimally invasive liver surgery for metastases from colorectal cancer: oncologic outcome and prognostic factors.

Molecular genetics of colorectal cancer

Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients

Oncological Management of Unresectable Liver Metastases ⬇️

PD-030Prospective non-interventional study to collect data on the use of bevacizumab and conventional chemotherapy for the treatment of previously untreated metastatic colorectal cancer in patient's ≥70 years.

PHD1 regulates p53-mediated colorectal cancer chemoresistance.

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

Phase II open-label study to assess efficacy and safety of lenalidomide in combination with cetuximab in KRAS-mutant metastatic colorectal cancer

Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma

Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus ⬇️

Postgastrectomy protein-losing cytomegalovirus jejunitis in an immunocompromised patient.

Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.

Progression of Barrett's esophagus toward esophageal adenocarcinoma: an overview

Proteomic analysis of formalin-fixed paraffin-embedded colorectal cancer tissue using tandem mass tag protein labeling.

Pulmonary lymphangitic carcinomatosis as a primary manifestation of gastric carcinoma in a young adult: a case report and review of the literature

RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review. ⬇️

RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment

Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study).

Refractory Metastatic Colorectal Cancer: Current Challenges and Future Prospects

Relevance of Geriatric Assessment in Older Patients With Colorectal Cancer.

Role of targeted agents in metastatic colorectal cancer.

Safety and efficacy of doxorubicin-eluting superabsorbent polymer microspheres for the treatment of liver metastases from neuroendocrine tumours: preliminary results

Salivary gland carcinomas: molecular abnormalities as potential therapeutic targets.

Simultaneous determination of AMN107 and Imatinib (Gleevec, Glivec, STI571) in cultured tumour cells using an isocratic high-performance liquid chromatography procedure with UV detection

Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions

Successful application of endoscopic ultrasound-guided fine needle biopsy to establish pancreatic patient-derived tumor xenografts: a pilot study

Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status

Tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome.

The impact of frailty on postoperative outcomes in individuals aged 65 and over undergoing elective surgery for colorectal cancer: A systematic review

The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia.

Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancer

Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancer

Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival.